EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    1.1.1.284 | Asthma |
18097950 |
Mechanistic considerations for formaldehyde-induced bronchoconstriction involving S-nitrosoglutathione reductase. |
causal interaction
unassigned |
2
0 |
| 1.1.1.284 | Asthma |
19395503 |
S-Nitrosoglutathione Reductase -- An Important Regulator in Human Asthma. |
causal interaction
ongoing research
unassigned |
4
2
0 |
| 1.1.1.284 | Asthma |
19514054 |
Genetic variants of GSNOR and ADRB2 influence response to albuterol in African-American children with severe asthma. |
causal interaction
therapeutic application
unassigned |
3
1
0 |
| 1.1.1.284 | Asthma |
20335826 |
GSNO reductase and beta2-adrenergic receptor gene-gene interaction: bronchodilator responsiveness to albuterol. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
2
2
4 |
| 1.1.1.284 | Asthma |
21784966 |
S-nitrosoglutathione Supplementation To Ovalbumin Sensitized and Challenged Mice Ameliorates Methacholine-Induced Bronchoconstriction. |
causal interaction
unassigned |
3
0 |
| 1.1.1.284 | Asthma |
21816964 |
S-Nitrosoglutathione reductase in human lung cancer. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
3
4
4 |
| 1.1.1.284 | Asthma |
21855338 |
Discovery of potent and novel S-nitrosoglutathione reductase inhibitors devoid of cytochrome P450 activities. |
causal interaction
therapeutic application
unassigned |
4
4
0 |
| 1.1.1.284 | Asthma |
22210450 |
A nonclinical safety and pharmacokinetic evaluation of N6022: a first-in-class S-nitrosoglutathione reductase inhibitor for the treatment of asthma. |
causal interaction
therapeutic application
unassigned |
2
4
0 |
| 1.1.1.284 | Asthma |
22335564 |
Mechanism of Inhibition for N6022, a First-in-Class Drug Targeting S-Nitrosoglutathione Reductase. |
therapeutic application
unassigned |
4
0 |
| 1.1.1.284 | Asthma |
22342142 |
Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: Carboxamide modification. |
causal interaction
ongoing research
therapeutic application
unassigned |
4
2
4
0 |
